Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Clin Microbiol ; 52(5): 1590-4, 2014 May.
Article in English | MEDLINE | ID: mdl-24599973

ABSTRACT

Our study is the first to compare the nasopharyngeal microbiota of pediatric pneumonia patients and control children by 454 pyrosequencing. A distinct microbiota was associated with different pneumonia etiologies. Viral pneumonia was associated with a high abundance of the operational taxonomic unit (OTU) corresponding to Moraxella lacunata. Patients with nonviral pneumonia showed high abundances of OTUs of three typical bacterial pathogens, Streptococcus pneumoniae complex, Haemophilus influenzae complex, and Moraxella catarrhalis. Patients classified as having no definitive etiology harbored microbiota particularly enriched in the H. influenzae complex. We did not observe a commensal taxon specifically associated with health. The microbiota of the healthy nasopharynx was more diverse and contained a wider range of less abundant taxa.


Subject(s)
Microbiota/genetics , Nasopharynx/microbiology , Nasopharynx/virology , Pneumonia/microbiology , Pneumonia/virology , Adolescent , Case-Control Studies , Child , Child, Preschool , Haemophilus Infections/diagnosis , Haemophilus Infections/microbiology , Haemophilus influenzae/genetics , Humans , Infant , Moraxella catarrhalis/genetics , Moraxellaceae Infections/diagnosis , Moraxellaceae Infections/microbiology , Pneumococcal Infections/diagnosis , Pneumococcal Infections/microbiology , Pneumonia/diagnosis , Prospective Studies , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/virology , Streptococcus pneumoniae/genetics
3.
Lipids Health Dis ; 12: 81, 2013 May 31.
Article in English | MEDLINE | ID: mdl-23725086

ABSTRACT

BACKGROUND: Inflammatory bowel diseases (IBD) are chronic intestinal inflammatory diseases affecting about 1% of western populations. New eating behaviors might contribute to the global emergence of IBD. Although the immunoregulatory effects of omega-3 fatty acids have been well characterized in vitro, their role in IBD is controversial. METHODS: The aim of this study was to assess the impact of increased fish oil intake on colonic gene expression, eicosanoid metabolism and development of colitis in a mouse model of IBD. Rag-2 deficient mice were fed fish oil (FO) enriched in omega-3 fatty acids i.e. EPA and DHA or control diet for 4 weeks before colitis induction by adoptive transfer of naïve T cells and maintained in the same diet for 4 additional weeks. Onset of colitis was monitored by colonoscopy and further confirmed by immunological examinations. Whole genome expression profiling was made and eicosanoids were measured by HPLC-MS/MS in colonic samples. RESULTS: A significant reduction of colonic proinflammatory eicosanoids in FO fed mice compared to control was observed. However, neither alteration of colonic gene expression signature nor reduction in IBD scores was observed under FO diet. CONCLUSION: Thus, increased intake of dietary FO did not prevent experimental colitis.


Subject(s)
Colitis/diet therapy , Colitis/metabolism , Eicosanoids/metabolism , Fish Oils/pharmacology , Intestines/drug effects , Animals , Colitis/genetics , Colon/physiopathology , Cytokines/metabolism , DNA-Binding Proteins/genetics , Disease Models, Animal , Fatty Acids, Omega-3/pharmacology , Fish Oils/chemistry , Gene Expression Regulation/drug effects , Inflammatory Bowel Diseases/etiology , Intestinal Mucosa/metabolism , Mice, Inbred C57BL , Mice, Mutant Strains , T-Lymphocytes, Helper-Inducer/metabolism , T-Lymphocytes, Helper-Inducer/pathology
4.
Int J Food Microbiol ; 289: 30-39, 2019 Jan 16.
Article in English | MEDLINE | ID: mdl-30193123

ABSTRACT

Listeria monocytogenes is a major foodborne pathogen. Testing multiple portions of the same final product is often required to verify the effectiveness of a food safety management system. Therefore, it will be advantageous to the laboratories to combine these test portions and process as one sample. However, combining samples for analysis, i.e., pooling, can be done only if there is no negative impact on the result. The objective of this study was to validate pooling of test portions for the detection of L. monocytogenes and Listeria spp. in dairy products as no scientific evidence currently exists to support this practice. Six representative matrices, namely, pudding, yogurt, brie cheese, 2% milk, ice cream and infant formula were spiked separately with stressed L. monocytogenes and Listeria spp. in 25 g and pooled test portions (375 g/250 g/125 g). Two methods, namely, ISO-11290-1:1996 Amd1:2004 and a validated alternative method Rapid'L.Mono were used for sample testing. Performance of a method in pooled test portions was considered to be satisfactory if the relative limit of detection (RLOD50; LOD50 [pooled test portion]/LOD50 [25 g test portion]) and limit of detection (LOD50) obtained was ≤2.5 and 1 CFU or MPN, respectively. Results obtained from L. monocytogenes and Listeria spp. trials were given equal weightage to decide on the impact of pooling. Acceptable RLOD50 and LOD50 values were consistently obtained in L. monocytogenes and Listeria spp. inoculation experiments when test portions were pooled up to 125 g for all matrices tested with both methods. While there was a slight delay for the primary enrichment of the pooled test portions to reach the desired incubation temperature when compared to the 25 g test portions, it did not negatively impact the outcome when samples were pooled up to 125 g. Background organisms were in general present at low concentrations and did not seem to adversely impact the recovery of the target organism in 125 g samples. Thus, pooling of test portions to up to 125 g for the detection of L. monocytogenes and Listeria spp. by two culture methods in processed dairy products has been validated.


Subject(s)
Dairy Products/microbiology , Food Microbiology/methods , Listeria/isolation & purification , Food Microbiology/standards , Limit of Detection , Listeria monocytogenes
5.
Nutrients ; 10(5)2018 May 15.
Article in English | MEDLINE | ID: mdl-29762503

ABSTRACT

Phospholipids (PL) or partial acylglycerols such as sn-1(3)-monoacylglycerol (MAG) are potent dietary carriers of long-chain polyunsaturated fatty acids (LC-PUFA) and have been reported to provide superior bioavailability when compared to conventional triacylglycerol (TAG). The main objective of the present study was to compare the incorporation of docosahexaenoic acid (DHA) in plasma, erythrocytes, retina and brain tissues in adult rats when provided as PL (PL-DHA) and MAG (MAG-DHA). Conventional dietary DHA oil containing TAG (TAG-DHA) as well as control chow diet were used to evaluate the potency of the two alternative DHA carriers over a 60-day feeding period. Fatty acid profiles were determined in erythrocytes and plasma lipids at time 0, 7, 14, 28, 35 and 49 days of the experimental period and in retina, cortex, hypothalamus, and hippocampus at 60 days. The assessment of the longitudinal evolution of DHA in erythrocyte and plasma lipids suggest that PL-DHA and MAG-DHA are efficient carriers of dietary DHA when compared to conventional DHA oil (TAG-DHA). Under these experimental conditions, both PL-DHA and MAG-DHA led to higher incorporations of DHA erythrocytes lipids compared to TAG-DHA group. After 60 days of supplementation, statistically significant increase in DHA level incorporated in neural tissues analyzed were observed in the DHA groups compared with the control. The mechanism explaining hypothetically the difference observed in circulatory lipids is discussed.


Subject(s)
Fatty Acids/pharmacokinetics , Monoglycerides/blood , Phospholipids/blood , Triglycerides/blood , Animals , Biological Availability , Body Composition , Diet , Dietary Fats/administration & dosage , Docosahexaenoic Acids/blood , Eicosapentaenoic Acid/blood , Erythrocytes/metabolism , Fatty Acids/administration & dosage , Fatty Acids/blood , Male , Monoglycerides/administration & dosage , Phospholipids/administration & dosage , Rats , Rats, Wistar , Sample Size , Soybean Oil/administration & dosage , Sunflower Oil/administration & dosage , Triglycerides/administration & dosage , Weight Gain
6.
J Nutr Biochem ; 24(1): 104-11, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22819560

ABSTRACT

The immunoregulatory effects of dietary omega-3 fatty acids are still not fully characterized. The aim of this study was to determine whether dietary eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake limits intestinal ischemia-reperfusion (IR) injury. To test this, rats were fed either control or EPA/DHA supplemented diet for 3 weeks following which they underwent either a sham or an IR surgical protocol. A significant reduction in mucosal damage was observed after EPA/DHA supplemented diet as reflected by maintenance of total protein content. To address the underlying mechanisms of protection, we measured parameters of oxidative stress, intestinal and serological cytokines and intestinal eicosanoids. Interestingly, EPA/DHA fed animals displayed a higher activity of oxidative stress enzyme machinery, i.e., superoxide dismutase and catalase in addition to a reduction in total nitrate/nitrite content. While no changes in cytokines were observed, eicosanoid analyses of intestinal tissue revealed an increase in metabolites of the 12-lipoxygenase pathway following IR. Further, IR in EPA/DHA fed animals was accompanied by a significant increase of 17,18-epoxyeicosatetraenoic acid, 8-Iso prostaglandin F(3α) and thromboxane B(3), by more than 12-, 6-, 3-fold, respectively. Thus, the data indicate that EPA/DHA supplementation may be able to reduce early intestinal IR injury by anti-oxidative and anti-inflammatory mechanisms.


Subject(s)
Docosahexaenoic Acids/pharmacology , Eicosapentaenoic Acid/pharmacology , Intestines/blood supply , Intestines/drug effects , Reperfusion Injury/prevention & control , Animals , Arachidonate 12-Lipoxygenase/metabolism , Arachidonic Acids/metabolism , Catalase/metabolism , Cytokines/metabolism , Dietary Supplements , Eicosanoids/metabolism , Fatty Acids/analysis , Fatty Acids/chemistry , Intestinal Mucosa/metabolism , Intestine, Small/drug effects , Intestine, Small/metabolism , Male , Mesenteric Arteries/surgery , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Reperfusion Injury/metabolism , Superoxide Dismutase/metabolism , Thromboxanes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL